Loading clinical trials...
Loading clinical trials...
An Open-Label, First-in-Human, Single Intervention Study for Evaluation of EpiBone-CMF Engineered Living Bone Graft for Mandibular Ramus Reconstruction
Conditions
Interventions
EB-CMF
Locations
3
United States
VA Healthcare System, San Francisco
San Francisco, California, United States
Cleveland Clinic
Cleveland, Ohio, United States
UT Health San Antonio
San Antonio, Texas, United States
Start Date
March 31, 2021
Primary Completion Date
August 1, 2023
Completion Date
November 1, 2023
Last Updated
May 27, 2022
NCT05987930
NCT05602909
NCT00628849
Lead Sponsor
Epibone, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions